ERAS

Erasca Stock Analysis

AI Rating

Neutral
  • Quality1/10
  • Growth↓ 1/10
  • Value↑ 6/10
Erasca sales and earnings growth
ERAS Growth
Low
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -55.00%
  • FCF Y/Y↑ 15.26%
Erasca gross and profit margin trends
ERAS Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -48.18%
Erasca net debt vs free cash flow
ERAS Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Erasca stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks